Many people recovered from COVID-19 expecting life to return to normal. But for some, something didn’t. Weeks or months later, new digestive symptoms appeared: bloating, abdominal pain, diarrhea or constipation, urgency after meals and new food sensitivities.
If this sounds familiar, you may be experiencing what doctors now recognize as post-COVID IBS. And you’re not alone.
What Is Post-COVID IBS?
Irritable Bowel Syndrome (IBS) is a disorder of gut–brain interaction - meaning the digestive system becomes more sensitive and reactive, even though routine tests look normal. These conditions are common and can significantly affect daily life and productivity. For decades, doctors have known IBS can develop after infections like food poisoning. Research now shows COVID-19 can also trigger IBS in some people.1,2
Recent analyses suggest roughly 7% of people develop IBS after COVID infection10, with higher risk compared to people who were never infected. That may sound small, but given how widespread COVID infections were, this represents millions of people worldwide.
Why Would COVID Affect the Gut?
COVID is often thought of as a respiratory illness, but it also affects the digestive system. That’s because the virus uses ACE2 receptors to enter cells and these receptors are abundant in the intestines.2,3
During infection with the virus, viral RNA is detected in about half of patients’ stool while around 10% report digestive symptoms. Intestinal inflammation can occur3. Even after recovery, some of these changes may persist.
What Changes in the Gut After COVID?
Scientists believe post-COVID IBS can develop through several overlapping biological changes:
1. Gut Microbiome Disruption: COVID can alter the balance of healthy gut bacteria while boosting pathogenic ones, including reductions in beneficial anti-inflammatory microbes such as Faecalibacterium prausnitzii.4,5,6
2. Ongoing Low-Grade Inflammation: COVID infection can trigger inflammation in the intestines, sometimes reflected by elevated fecal inflammatory markers.3
3. A More Sensitive Gut Nervous System: IBS is partly a condition of nerve signaling. Post-infection immune activity, stress, and gut changes can make digestive nerves more reactive, increasing pain and urgency.7
4. Stress and the Gut–Brain Connection: Stress strongly affects digestion. The pandemic increased anxiety and psychological strain worldwide, and these factors can worsen or trigger IBS symptoms.8
Why Certain Foods Suddenly Trigger Symptoms
Many people with post-COVID IBS may notice that foods like onion, garlic, beans, dairy, wheat suddenly cause bloating, abdominal pain or diarrhea. These foods contain FODMAPs - fermentable carbohydrates that draw water into the intestine, feed gut bacteria, and produce gas. In a sensitive gut, that combination can trigger symptoms quickly.
Who Is More Likely to Develop Post-COVID IBS?
Research suggests higher risk in people who had9:
- Digestive symptoms during COVID
- More severe infection
- Loss of smell or taste
- Ongoing symptoms 1 month after illness
- Anxiety or depression
- Female sex
The Good News: Post-COVID IBS Is Manageable
Post-COVID IBS does not mean permanent damage.
It usually means the gut’s immune, nervous, and microbial systems are temporarily out of balance. Many people improve with: diet adjustments, stress management, microbiome care and targeted digestive support.
How Digestive Enzyme Supplements May Help
One helpful strategy for people sensitive to certain foods is reducing the amount of fermentable carbohydrates that reach the colon.
Targeted digestive enzyme supplements can help break down specific FODMAP carbohydrates, including: fructans (onion, garlic, wheat), GOS (beans, lentils) and lactose (dairy)
When these compounds are digested earlier: less fermentation occurs in the colon, gas production may decrease and pain, bloating and urgency may be reduced.
Digestive enzymes do not cure IBS, but reducing fermentable substrates can lower symptom triggers by decreasing gas production and intestinal distension. With the right support, many people see meaningful improvement.
References:
1. Schmulson M et al. Rev Gastroenterol Mex. 2020.
2. Schmulson M et al. Am J Gastroenterol. 2021.
3. Effenberger M et al. Gut. 2020.
4. Zuo T et al. Gastroenterology. 2020.
5. Barbara G et al. Gastroenterology. 2019.
6. Barbara G et al. Curr Opin Gastroenterol. 2014.
7. Barbara G et al. Gastroenterology. 2016.
8. Oshima T et al. J Gastroenterol Hepatol. 2021.
9. Chan W et al. Clin Gastroenterol Hepatol 2022.
10. Ghoshal UC et al. Neurogastroenterology & Motility. 2026.